Specialties

Prostate Cancer

For nearly a century marked by painstaking, pioneering research, scientists at the Brady Urological Institute at Johns Hopkins—the top-ranked urology department in the United States--have led the world's efforts to diagnose and treat prostate cancer. The James Buchanan Brady Urological Institute was the first Institution to perform several landmark operations including:

• First Radical Prostatectomy
• Perineal Prostatectomy
• Nerve Sparing Radical Retropubic Prostatectomy
• Transurethral Resection of the Prostate

Twenty years ago, prostate cancer surgery was dangerous with devastating side effects. Today, radical prostatectomy cures the vast majority of men with cancer confined to the prostate.  Serious bleeding is very rare, preserving potency is common, and few suffer from serious incontinence. In fact, the radical prostatectomy at the Brady Urological Institute is considered to be the gold standard for cancer cure, to which all other forms of treatment are compared. 

But despite tremendous success there is no single "magic bullet" that will cure the disease in every man.  Our experts stay on top of the latest treatments and technological advances. This not only furthers our knowledge, but also yields better results for patients.  Dr. Patrick Walsh, who developed the nerve-sparing retropubic prostatectomy, and Dr. David Coffey, Research Director, lead the Institute's programs and its team of experts.

Continuing the department’s pioneering tradition, surgeons at Brady have now developed a minimally-invasive version of the surgery that Dr. Walsh developed decades ago and continue to do research to find better and more effective treatments.